SKI Market

Indian Indices

Sensex

83,246.18 -324.17
( -0.39%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,565.61 -370.56
(-0.69%)

Nikkei 225

10,200.95 -34.34
(-0.34%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

172.5

38.5

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Linc consolidated net profit declines 3.75% in the September 2025 quarter

Nov 10,2025

Net profit of Linc declined 3.75% to Rs 8.46 crore in the quarter ended September 2025 as against Rs 8.79 crore during the previous quarter ended September 2024. Sales rose 1.30% to Rs 139.07 crore in the quarter ended September 2025 as against Rs 137.28 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	139.07	137.28	1
OPM %	11.27	11.87	-
PBDT	17.22	15.58	11
PBT	13.44	11.80	14
NP	8.46	8.79	-4

83,246.18 -324.17 ( -0.39%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,565.61 -370.56 (-0.69%)

10,200.95 -34.34 (-0.34%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)